Companies / Syndax Pharmaceuticals Inc / Activity
Activity — Syndax Pharmaceuticals Inc
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Metzger Michael A CEO | Sell | Common Stock | $360.8K | -17K -3.37% | 491,690 0.55% of shares | medium |
| Feb 6, 2026 | Metzger Michael A CEO | Sell | Common Stock | $152.8K | -7K -1.44% | 508,849 0.57% of shares | medium |
| Jun 1, 2026 | Metzger Michael A CEO | Sell | Common Stock | $130.0K | -7K -1.39% | 484,843 0.54% of shares | medium |
| Feb 4, 2026 | Metzger Michael A CEO | Grant | Common Stock | $0 | +145K +38.91% | 516,261 0.58% of shares | low |
| Feb 4, 2026 | Metzger Michael A CEO | Grant | Common Stock | $0 | +73K +24.44% | 371,661 0.42% of shares | low |
| Feb 4, 2026 | Metzger Michael A CEO | Grant | Stock Options (Right to buy) | — | +440K | 440,000 0.49% of shares | low |